1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with acetylsalicylic acid lysinate in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (acetylsalicylic acid lysinate) | Trials (acetylsalicylic acid lysinate) | Recent Studies (post-2010) (acetylsalicylic acid lysinate) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 326 | 91 | 26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrigón, S; Salinas, P | 1 |
| Arnout, J; Deckmyn, H; Hoet, B; Kienast, J; Pfliegler, G; Vermylen, J; Wittevrongel, C | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and acetylsalicylic acid lysinate
| Article | Year |
|---|---|
Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Imidazoles; Lysine; Ouabain; Platelet Activating Factor; Thromboxane-A Synthase | 1991 |
Sodium fluoride induced activation of phospholipase C in intact human platelets does not depend on ADP, PAF or arachidonate products.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Enzyme Activation; GTP-Binding Proteins; Humans; Lysine; Phospholipid Ethers; Platelet Activating Factor; Sodium Fluoride; Type C Phospholipases | 1993 |